How might the NovoTTF-100L System help people live longer?

The majority of people who used NovoTTF-100L + chemotherapy saw their mesothelioma shrink or stop growing

Learn more about study results for NovoTTF-100L™ + chemo

A clinical study showed that using NovoTTF-100L + chemotherapy provided

A clinical study showed that using NovoTTF-100L + chemotherapy provided survival rate at 1 year 62%, and 42% at 2 years
NovoTTF-100L + chemotherapy helped prevent tumor growth without adding to chemotherapy-related side effects

NovoTTF-100L treats where your mesothelioma is located

NovoTTF-100L™ device

Unlike a drug, NovoTTF-100L does not enter the bloodstream, so it does not cause chemotherapy-related side effects.

  • In the clinical study, the only side effect of NovoTTF-100L was skin irritation seen in 71% of patients (66% mild to moderate and 5% severe)
    • Most skin irritation is reversible and can be treated with topical ointments, creams, or solutions prescribed by your doctor

References: 1. NovoTTF-100L Patient Information and Prescribing Manual. Novocure 2019. 2. Novocure Data on File Opt-139.1. 3. NovoTTF-100L Instructions For Use for Unresectable Malignant Pleural. Novocure 2019.

Next: Daily life with NovoTTF-100L
Back to top
What is the NovoTTF-100L™ System approved to treat?
jump to isi

The NovoTTF-100L System is a wearable, portable, FDA-approved device indicated for…